Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Drug Safety
|
September 30, 2020
Assessing the Safety of COVID-19 Vaccines: A Primer
Helen Petousis-Harris
Vaccine
|
September 23, 2008
Vaccine injection technique and reactogenicity--evidence for practice
Helen Petousis-Harris
Human Vaccines & Immunotherapeutics
|
October 20, 2017
Impact of meningococcal group B OMV vaccines, beyond their brief
Helen Petousis-Harris
Frontiers in Immunology
|
April 27, 2019
Exploitation of <i>Neisseria meningitidis</i> Group B OMV Vaccines Against <i>N. gonorrhoeae</i> to Inform the Development and Deployment of Effective Gonorrhea Vaccines
Helen Petousis-Harris, Fiona J Radcliff
Vaccine
|
September 23, 2008
MeNZB vaccine and epidemic control: when do you stop vaccinating?
Belinda J Loring, Nikki Turner, Helen Petousis-Harris
Journal of Primary Health Care
|
August 10, 2010
The cost of immunising at the general practice level
Nikki Turner, Paul Rouse, Stacey Airey, et al.
Vaccines
|
July 19, 2019
Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol
Hannah Chisholm, Anna Howe, Emma Best, et al.
Vaccine
|
June 6, 2012
Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance
Helen Petousis-Harris, Tracey Poole, Nikki Turner, et al.
Vaccine
|
February 23, 2011
Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under
Helen Petousis-Harris, Tracey Poole, Robert Booy, et al.
Vaccine
|
May 20, 2004
Family physician perspectives on barriers to childhood immunisation
Helen Petousis-Harris, Felicity Goodyear-Smith, Nikki Turner, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Drug Safety
|
September 30, 2020
Assessing the Safety of COVID-19 Vaccines: A Primer
Helen Petousis-Harris
Vaccine
|
September 23, 2008
Vaccine injection technique and reactogenicity--evidence for practice
Helen Petousis-Harris
Human Vaccines & Immunotherapeutics
|
October 20, 2017
Impact of meningococcal group B OMV vaccines, beyond their brief
Helen Petousis-Harris
Frontiers in Immunology
|
April 27, 2019
Exploitation of <i>Neisseria meningitidis</i> Group B OMV Vaccines Against <i>N. gonorrhoeae</i> to Inform the Development and Deployment of Effective Gonorrhea Vaccines
Helen Petousis-Harris, Fiona J Radcliff
Vaccine
|
September 23, 2008
MeNZB vaccine and epidemic control: when do you stop vaccinating?
Belinda J Loring, Nikki Turner, Helen Petousis-Harris
Journal of Primary Health Care
|
August 10, 2010
The cost of immunising at the general practice level
Nikki Turner, Paul Rouse, Stacey Airey, et al.
Vaccines
|
July 19, 2019
Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol
Hannah Chisholm, Anna Howe, Emma Best, et al.
Vaccine
|
June 6, 2012
Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance
Helen Petousis-Harris, Tracey Poole, Nikki Turner, et al.
Vaccine
|
February 23, 2011
Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under
Helen Petousis-Harris, Tracey Poole, Robert Booy, et al.
Vaccine
|
May 20, 2004
Family physician perspectives on barriers to childhood immunisation
Helen Petousis-Harris, Felicity Goodyear-Smith, Nikki Turner, et al.
Page
of 6